Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Salicylic acid 2% ointment
1305020S0AAABAB
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 457 |
|
Salicylic acid 5% ointment in a base
1305020S0AACZCZ
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 86 |
|
Salicylic acid 2% in Aqueous cream
1305020S0AACSCS
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 40 |
|
Zinc and Salicylic acid paste
1305020S0AACUCU
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 34 |
|
Salicylic acid 10% in Aqueous cream
1305020S0AACRCR
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 31 |
|
Salicylic acid 5% cream
1305020S0AAA4A4
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 24 |
|
Salicylic acid 25% in White soft paraffin
1305020S0AACJCJ
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 12 |
|
Salicylic acid 2% in Generic Unguentum M cream
1305020S0AACVCV
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 9 |
|
Salicylic acid 20% in Aqueous cream
1305020S0AABPBP
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 9 |
|
Salicylic acid 2% in Emulsifying ointment
1305020S0AACHCH
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 8 |
|
Salicylic acid 1% in Aqueous cream
1305020S0AACTCT
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 6 |
|
Salicylic acid 2% lotion
1305020S0AAAEAE
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 5 |
|
Salicylic acid 5% in Generic Unguentum M cream
1305020S0AACWCW
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 3 |
|
Salicylic acid 2% in White soft paraffin
1305020S0AACCCC
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 2 |
|
Salicylic acid 4% in Aqueous cream
1305020S0AADMDM
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 2 |
|
Salicylic acid 6% in Aqueous cream
1305020S0AADHDH
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 2 |
|
Salicylic acid 3% in Aqueous cream
1305020S0AABTBT
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 1 |
|
Salicylic acid 40% in Yellow soft paraffin
1305020S0AABUBU
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 1 |
|
Salicylic acid 5% in Aqueous cream
1305020S0AADTDT
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 1 |
|
Salicylic acid 50% in Emulsifying ointment
1305020S0AADPDP
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 1 |
|
Lassar's paste
1305020S0AAACAC
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | No data available |
|
Salicylic acid 1.5% cream
1305020S0AADSDS
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | No data available |
|
Salicylic acid 1% in Emulsifying ointment
1305020S0AADADA
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | No data available |
|
Salicylic acid 1% in White soft paraffin
1305020S0AADLDL
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | No data available |
|
Salicylic acid 1% in Yellow soft paraffin
1305020S0AACQCQ
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.